Acrovin 500mg Injection (Tirofiban): Comprehensive Medicine Guide
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026
When to Call Your Doctor IMMEDIATELY
- Severe headache with confusion or vision changes
- Blood in urine or black, tarry stools
- Vomiting blood or coffee-ground material
- Sudden severe back or flank pain
- Difficulty breathing or swelling of face, lips, or throat
- Uncontrolled bleeding from any site
- Fainting or severe dizziness
If experiencing severe symptoms, call emergency services immediately.
What is acrovin 500mg injection used for?
This medicine is a potent intravenous antiplatelet drug used in acute coronary syndromes and during angioplasty to prevent blood clots. It works by blocking platelet aggregation and is given only in hospital settings under close supervision.
- Generic Name: Tirofiban (500mg)
- Manufacturer: Vintech Formulations
- Form: Allopathy
- Pregnancy Category: Consult doctor
- Prescription Required: Yes
🇮🇳 acrovin 500mg injection के बारे में (Hindi Summary)
उपयोग: यह दवा टिरोफिबान नामक एक शक्तिशाली एंटीप्लेटलेट एजेंट है, जिसका उपयोग अस्पताल में तीव्र कोरोनरी सिंड्रोम (जैसे अस्थिर एनजाइना या दिल का दौरा) और एंजियोप्लास्टी के दौरान रक्त के थक्के बनने से रोकने के लिए किया जाता है। यह केवल इंजेक्शन के रूप में दी जाती है और इसका उपयोग डॉक्टर की देखरेख में ही किया जाता है। यह प्लेटलेट्स को एक साथ चिपकने से रोकती है, जिससे हृदय की धमनियों में थक्का नहीं बनता।
साइड इफेक्ट्स: इस दवा के सबसे आम दुष्प्रभावों में रक्तस्राव शामिल है, जैसे इंजेक्शन स्थल पर खून आना, नाक से खून आना, या आसानी से चोट लगना। कभी-कभी गंभीर रक्तस्राव जैसे मस्तिष्क में रक्तस्राव या पेट में रक्तस्राव हो सकता है। प्लेटलेट्स की संख्या कम हो सकती है, जिससे रक्तस्राव का खतरा बढ़ जाता है। कुछ रोगियों में एलर्जी, जी मिचलाना, या सिरदर्द भी हो सकता है। कोई भी असामान्य लक्षण दिखने पर तुरंत डॉक्टर को बताएं।
सुरक्षा सलाह: यह दवा केवल अस्पताल में योग्य चिकित्सक द्वारा ही दी जानी चाहिए। इसका उपयोग घर पर स्वयं न करें। इस दवा को लेने से पहले अपने डॉक्टर को सभी दवाओं, विशेषकर रक्त पतला करने वाली दवाओं के बारे में बताएं। उपचार के दौरान रक्तस्राव की निगरानी की जाती है। चोट लगने से बचें और तेज धार वाली वस्तुओं का उपयोग न करें। यदि आपको असामान्य रक्तस्राव, सिरदर्द, या चक्कर आना महसूस हो, तो तुरंत चिकित्सा सहायता लें।
💊 acrovin 500mg injection Uses & Benefits
[{"condition":"Acute Coronary Syndrome (Unstable Angina/Non-ST-Elevation Myocardial Infarction)","description":"Used to reduce the risk of thrombotic cardiovascular events in patients with unstable angina or non-ST-elevation myocardial infarction, especially when percutaneous coronary intervention is planned.","evidence":"Well-established"},{"condition":"Percutaneous Coronary Intervention (PCI)","description":"Administered during PCI to prevent abrupt closure of the coronary artery and reduce ischemic complications in patients with high-risk features.","evidence":"Well-established"},{"condition":"ST-Elevation Myocardial Infarction (STEMI) undergoing primary PCI","description":"May be used as an adjunct to heparin and aspirin in patients undergoing primary angioplasty for STEMI to improve coronary flow and reduce recurrent ischemia.","evidence":"Established in selected patients"}]
Off-label uses: [{"condition":"Prevention of thrombotic complications during carotid artery stenting","description":"Occasionally used off-label during carotid stenting to prevent thromboembolic events, though evidence is limited.","evidence":"Limited"},{"condition":"Adjunctive therapy in mechanical thrombectomy for acute ischemic stroke","description":"Investigated in some centers as an adjunct to mechanical thrombectomy, but not standard of care.","evidence":"Investigational"}]
Primary treatment for: Acute Coronary Syndrome
Also treats: Unstable Angina, Non-ST-Elevation Myocardial Infarction, ST-Elevation Myocardial Infarction (adjunct to PCI)
📋 Drug Information
| Generic Name(s) | Tirofiban (500mg) |
| Brand Name | acrovin 500mg injection |
| Manufacturer | Vintech Formulations |
| Packaging / Form | Varies by brand (Allopathy) |
| Therapeutic Class | BLOOD RELATED |
| Action Class | Glycoprotein IIb/IIIa inhibitors |
| Route of Administration | Parenteral (intravenous infusion) |
| Storage | Store vials refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. Once diluted, the solution should be used immediately or stored as per institutional guidelines, typically not exceeding 24 hours under refrigeration. |
| Shelf Life | The shelf life of the unopened vial is typically 24 months from the date of manufacture. After dilution, the stability is limited; refer to the product labeling for specific storage times. |
| WHO Guideline | The World Health Organization does not have specific guidelines for tirofiban. Management of acute coronary syndromes is guided by regional and international cardiology societies. |
| ICMR Guideline | The Indian Council of Medical Research has not issued specific guidelines for tirofiban. Indian cardiology societies follow international guidelines for ACS management. |
👨⚕️ Doctor's Practical Tips
Evidence-based practical advice from experienced clinicians
🔍 Is This Medicine Right for Your Symptom?
Educational reference. Always consult a doctor for diagnosis.
🔬 How This Medicine Works (Pharmacology)
Pharmacokinetics
How It Works
This medicine works by selectively binding to the glycoprotein IIb/IIIa receptor on the surface of activated platelets. This receptor is the final common pathway for platelet aggregation, as it binds fibrinogen and von Willebrand factor to cross-link platelets. By occupying this receptor, tirofiban prevents fibrinogen binding and thus inhibits platelet aggregation. This action is reversible upon discontinuation of the infusion. The medicine does not affect platelet adhesion or secretion directly but effectively blocks the amplification of thrombus formation. Its rapid onset and short duration of action make it suitable for acute settings where precise control of platelet inhibition is required.
Mechanism Steps
💡 How to Take acrovin 500mg injection
Strength: This medicine is available as a 500 mg strength injection, which is a concentrated formulation intended for dilution prior to intravenous infusion. The actual administered dose is based on micrograms per kilogram of body weight, not the total vial content.
Dosage Information
| Adult Dosage | The dosage of this medicine must be individualized by a qualified clinician based on the patient's clinical condition, renal function, and concomitant medications. For acute coronary syndromes, a common regimen involves an initial loading infusion of 0.4 mcg/kg/min for 30 minutes, followed by a maintenance infusion of 0.1 mcg/kg/min for up to 48 hours. For percutaneous coronary intervention, a loading dose of 10 mcg/kg bolus over 3 minutes followed by 0.15 mcg/kg/min infusion for 18-24 hours may be used. Dose reduction is required in severe renal impairment. Always follow institutional protocols and the latest guidelines. |
| Pediatric Dosage | Pediatric dosing is not established from available information. Consult a pediatrician. |
| Elderly Dosage | Elderly patients may have reduced renal function and are at higher risk of bleeding. Dose should be carefully adjusted based on creatinine clearance. No specific dose adjustment is recommended solely based on age, but close monitoring is advised. |
| Renal Impairment | In patients with creatinine clearance less than 30 mL/min, the dose should be reduced. For the loading infusion, a dose of 0.2 mcg/kg/min for 30 minutes is recommended, followed by a maintenance infusion of 0.05 mcg/kg/min. For bolus administration, a dose of 5 mcg/kg is suggested. These adjustments are based on pharmacokinetic data and should be individualized. |
| Hepatic Impairment | No specific dose adjustment is provided for hepatic impairment. Tirofiban is not extensively metabolized by the liver, so hepatic impairment is unlikely to significantly affect its clearance. However, use with caution in patients with severe hepatic impairment due to potential bleeding risk. |
| Maximum Daily Dose | The maximum recommended dose is determined by the specific regimen and patient weight. For the maintenance infusion, the dose should not exceed 0.15 mcg/kg/min. The total daily dose should not exceed the recommended cumulative dose for the indicated duration. Always adhere to the prescribed protocol. |
Dosage Timeline
🍽️ Food Timing Guide
⏰ What to Do If You Miss a Dose
⚠️ Side Effects of acrovin 500mg injection
✅ Common Side Effects
🚨 Serious Side Effects
⚠️ Rare Side Effects
Consult your doctor if you experience any unusual symptoms.
🔬 Drug Interactions
| Drug | Severity | Effect |
|---|---|---|
| Heparin | Major | |
| Warfarin | Major | |
| DOACs | Major | |
| Thrombolytics | Major | |
| NSAIDs | Moderate | |
| Clopidogrel | Moderate | |
| Aspirin | Moderate | |
| SSRIs | Moderate | |
| Cimetidine | Minor | |
| Probenecid | Minor |
🚨 Major Interactions
- Heparin
- Warfarin
- Direct oral anticoagulants (DOACs)
- Thrombolytic agents (e.g., alteplase)
- NSAIDs
⚡ Moderate Interactions
- Clopidogrel
- Aspirin
- Dipyridamole
- SSRIs
🍷 Alcohol Interaction
Alcohol should be avoided while receiving this medicine because it can increase the risk of bleeding and may exacerbate gastrointestinal irritation. Patients should not consume alcohol during the infusion and for at least 24 hours after discontinuation, or as advised by their physician.
🔎 Check Your Other Medicines
Educational tool. Always confirm with your doctor or pharmacist.
🛡️ Safety & Warnings
🚫 Contraindications
["Active internal bleeding","History of bleeding diathesis or thrombocytopenia","Recent (within 30 days) gastrointestinal bleeding or surgery","Severe uncontrolled hypertension","Acute pericarditis","Known hypersensitivity to tirofiban or any component of the formulation","Concurrent use of another GP IIb/IIIa inhibitor"]
⚠️ Warnings & Precautions
["Bleeding risk: The most serious risk is bleeding. Monitor closely, especially at arterial access sites.","Thrombocytopenia: Monitor platelet counts; if platelets drop below 100,000/mm³, consider discontinuation.","Renal impairment: Reduce dose in patients with creatinine clearance
🤱 Lactation Safety
It is not known whether tirofiban is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
💊 Overdose Management
Overdose of tirofiban may result in severe bleeding. There is no specific antidote. Management should focus on discontinuation of the infusion and supportive care. Platelet transfusions may be considered to reverse the antiplatelet effect, but their efficacy is not well established. In case of significant bleeding, fresh frozen plasma or cryoprecipitate may be administered. Hemodialysis is not effective in removing tirofiban. Patients should be monitored closely until bleeding stops and vital signs stabilize.
⏰ Missed Dose
This medicine is administered as a continuous intravenous infusion in a hospital setting. If a dose is missed or an infusion is interrupted, the healthcare team will follow the institutional protocol, which may involve restarting the infusion at a reduced rate or administering a bolus. Patients should not attempt to self-administer or adjust the dose. Any interruption should be reported to the medical staff immediately.
Additional Safety Advice
This medicine must only be administered by a qualified healthcare professional in a hospital or specialized clinic equipped to manage bleeding complications. Patients should inform their doctor about all medications they are taking, especially blood thinners, anti-inflammatory drugs, and herbal supplements, as these can increase bleeding risk. Before receiving this medicine, a complete blood count and coagulation profile are typically checked. During infusion, frequent monitoring of vital signs and bleeding signs is necessary. Patients should avoid any activities that could cause injury or bleeding, such as contact sports or using sharp objects. If a dose is missed, it is important to follow the hospital protocol; do not attempt to self-administer. After discharge, patients should watch for delayed bleeding and report any unusual symptoms. It is crucial not to breastfeed while receiving this medicine, as safety has not been established. Always keep follow-up appointments for blood tests and cardiac evaluation.
👴 Special Considerations for Elderly
💡 For Patients Above 65
Elderly patients are at higher risk of bleeding due to age-related changes in renal function and increased fragility. Dose adjustment based on renal function is crucial. Close monitoring for bleeding signs is recommended. Falls prevention strategies should be implemented during hospitalization.
🤰 Pregnancy Planning (TTC)
This medicine should not be used during pregnancy unless clearly needed. If you are planning pregnancy, discuss with your doctor about alternative treatments. Effective contraception should be used during treatment. If pregnancy occurs during treatment, inform your doctor immediately.
🏥 Post-Surgery Considerations
If you have recently had surgery, this medicine may increase the risk of bleeding at the surgical site. It is generally avoided within 30 days of major surgery. Your doctor will assess the risks and benefits. After receiving this medicine, any planned surgery should be delayed until platelet function normalizes, usually 4-8 hours after discontinuation.
🦷 Dental Procedures
Dental procedures that involve bleeding should be avoided during treatment with this medicine and for at least 24 hours after discontinuation. Inform your dentist that you have received this medicine. Your dentist may recommend postponing non-urgent procedures.
💚 Lifestyle Tips for Better Results
🏋️ Exercise Considerations
After receiving this medicine, avoid strenuous exercise or activities that may cause injury for at least 24-48 hours. Contact sports and heavy lifting should be avoided to reduce bleeding risk. Gradually resume normal activities as advised by your doctor.
🥗 Diet Recommendations
💼 Impact on Daily Work & Life
This medicine is administered in a hospital, so it will not affect your work directly. However, you may need to take time off for the procedure and recovery. Driving and operating machinery should be avoided for at least 24 hours after discharge or as advised by your doctor. Most patients can resume normal activities within a few days, depending on their overall condition.
🛑 When to Stop This Medicine
This medicine is stopped by the healthcare team based on the treatment protocol, usually after 18-48 hours. Do not attempt to stop or adjust the infusion yourself. If you experience any serious side effects, the medical staff will decide whether to discontinue. After discharge, follow your doctor's instructions regarding oral medications.
📅 Long-Term Use Effects
This medicine is intended for short-term use only, typically during hospitalization for acute coronary syndromes or PCI. Long-term use is not recommended due to the high risk of bleeding. After discharge, patients are usually switched to oral antiplatelet agents. There are no known long-term effects from a single course of treatment, but bleeding risk may persist for a few hours after discontinuation. Regular follow-up with a cardiologist is important to monitor cardiovascular health and adjust medications.
🌿 Non-Medicine Approaches
These can complement medicine but do not replace prescribed treatment.
Used for long-term prevention after acute treatment.
Evidence: Well-establishedAlternatives for use during PCI, with different dosing and characteristics.
Evidence: Well-establishedA direct thrombin inhibitor that can be used as an alternative to heparin plus GP IIb/IIIa inhibitor in some patients.
Evidence: Established in selected patients💉 Vaccination Considerations
💉 If You're Getting Vaccinated
There are no known interactions between this medicine and vaccines. However, because it affects platelet function, it is advisable to avoid intramuscular injections, including some vaccines, during the infusion and for at least 24 hours after discontinuation to reduce bleeding risk. Consult your doctor for personalized advice.
📦 Storage Guide
✅ DO
Store vials refrigerated at 2°C to 8°C
❌ DON'T
Do not freeze
✅ DO
Protect from light
❌ DON'T
Do not use if solution is discolored or contains particles
✅ DO
Use diluted solution within the recommended time
❌ DON'T
Do not store diluted solution for more than 24 hours
✈️ Traveling with This Medicine
This medicine is administered only in a hospital setting, so travel advice is not applicable for self-administration. If you are traveling after discharge, carry a copy of your discharge summary and medication list. Ensure you have an adequate supply of oral antiplatelet medications as prescribed. Inform your doctor before any long trips, especially if you have a history of bleeding. Keep all medications in original packaging and carry them in your hand luggage. Check with your doctor about any travel restrictions or necessary precautions.
💰 Cost Analysis & Savings
👥 Real Patient Stories
Educational, anonymized scenarios. Individual results may vary.
💬 Questions Patients Often Ask
A: This medicine starts working within 5 minutes of intravenous administration, inhibiting platelet aggregation rapidly.
A: It is given as a continuous intravenous infusion in a hospital setting, usually through a dedicated line.
A: The most common side effect is bleeding, which may include bruising, nosebleeds, or bleeding at the injection site.
A: The dose may need to be reduced if you have severe kidney disease. Your doctor will adjust the dose based on your kidney function.
A: It is not known if this medicine passes into breast milk. Breastfeeding is not recommended during treatment.
🤔 Common Patient Concerns
🛑 Myths vs. Facts
- Myth: This medicine can be taken orally.
Fact: This medicine is only effective when given intravenously; oral administration is not effective. - Myth: This medicine is a painkiller for chest pain.
Fact: This medicine is not a painkiller; it is an antiplatelet agent that prevents clot formation. - Myth: This medicine can be used for long-term prevention of heart attacks.
Fact: This medicine is for short-term use in acute settings only; long-term use is not recommended.
🔄 Alternative Options
Generic Alternatives
- Tirofiban
Brand Alternatives
- Aggrastat